Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$1.5 - $3.07 $463 - $948
309 Added 2.3%
13,739 $22,000
Q2 2023

Jul 19, 2023

SELL
$1.79 - $2.9 $11,282 - $18,278
-6,303 Reduced 31.94%
13,430 $33,000
Q1 2023

May 12, 2023

BUY
$2.65 - $3.81 $641 - $922
242 Added 1.24%
19,733 $59,000
Q4 2022

Feb 10, 2023

SELL
$3.38 - $4.22 $20,209 - $25,231
-5,979 Reduced 23.47%
19,491 $71,000
Q3 2022

Nov 03, 2022

SELL
$3.43 - $5.83 $3,354 - $5,701
-978 Reduced 3.7%
25,470 $92,000
Q2 2022

Aug 09, 2022

SELL
$4.41 - $5.69 $39,787 - $51,335
-9,022 Reduced 25.44%
26,448 $140,000
Q1 2022

May 09, 2022

BUY
$4.81 - $6.99 $10,476 - $15,224
2,178 Added 6.54%
35,470 $195,000
Q4 2021

Feb 10, 2022

BUY
$5.97 - $7.93 $36,822 - $48,912
6,168 Added 22.74%
33,292 $227,000
Q3 2021

Nov 09, 2021

BUY
$4.79 - $6.68 $26,297 - $36,673
5,490 Added 25.38%
27,124 $165,000
Q2 2021

Aug 05, 2021

BUY
$5.35 - $6.35 $17,510 - $20,783
3,273 Added 17.83%
21,634 $128,000
Q1 2021

May 11, 2021

BUY
$5.68 - $7.87 $19,419 - $26,907
3,419 Added 22.88%
18,361 $110,000
Q4 2020

Feb 11, 2021

BUY
$5.25 - $8.56 $78,445 - $127,903
14,942 New
14,942 $103,000
Q4 2018

Mar 04, 2019

SELL
$4.89 - $7.16 $74,787 - $109,505
-15,294 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$6.89 - $7.78 $72,682 - $82,071
-10,549 Reduced 40.82%
15,294 $110,000
Q2 2018

Aug 06, 2018

SELL
$5.19 - $7.25 $12,419 - $17,349
-2,393 Reduced 8.47%
25,843 $172,000
Q1 2018

May 08, 2018

SELL
$3.56 - $5.74 $31,740 - $51,177
-8,916 Reduced 24.0%
28,236 $155,000
Q4 2017

Feb 06, 2018

BUY
$2.76 - $3.95 $102,539 - $146,750
37,152
37,152 $126,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $257M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.